|
Volumn 23, Issue 11, 2013, Pages 3262-3266
|
Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors
|
Author keywords
Alkyl anilide conformation; Conformation constraint; Non ATP competitive MK2 inhibitors
|
Indexed keywords
ADALIMUMAB;
ADENOSINE TRIPHOSPHATE;
ANILIDE;
ETANERCEPT;
INFLIXIMAB;
LACTAM DERIVATIVE;
MITOGEN ACTIVATED PROTEIN KINASE P38;
MITOGEN ACTIVATED PROTEIN KINASE P38 ACTIVATED PROTEIN KINASE 2;
MITOGEN ACTIVATED PROTEIN KINASE P38 ACTIVATED PROTEIN KINASE 2 INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
CHEMICAL BOND;
COMPETITIVE INHIBITION;
CONFORMATION CONSTRAINT;
CONFORMATIONAL TRANSITION;
CYTOKINE PRODUCTION;
CYTOPATHOGENIC EFFECT;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG IDENTIFICATION;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME ASSAY;
ENZYME INHIBITION;
ENZYME SPECIFICITY;
HUMAN;
HUMAN CELL;
IC 50;
PROCESS OPTIMIZATION;
REPRODUCIBILITY;
STRUCTURE ACTIVITY RELATION;
ADENOSINE TRIPHOSPHATE;
ANILIDES;
BINDING, COMPETITIVE;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
LACTAMS;
PROTEIN BINDING;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84877583945
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.03.109 Document Type: Article |
Times cited : (22)
|
References (24)
|